Follow the people · Insider
Joseph A. Tyndall
Joseph A. Tyndall files insider transactions with the SEC as a director of Axogen (AXGN). We hold 1 disclosed purchase or sale filed since 15 December 2022, 1 of them in the last 90 days.
- Files forAXGN
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure4 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 December 2022 — 2 September 2026Director · Axogen (AXGN)29 Form 4 lines · source: SEC Form 4
Everything they disclosed
29 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 3,500 shares of AxogenSEC Form 44 September 2026Common Stock · traded 2 September 2026 · filed 4 September 2026
- was granted 4,392 shares of Axogen (a derivative holding)SEC Form 426 June 2026Restricted Stock Units · traded 24 June 2026 · filed 26 June 2026
- exercised options over 14,150 shares of AxogenSEC Form 423 June 2026Common Stock · traded 19 June 2026 · filed 23 June 2026
- exercised options over 14,150 shares of Axogen (a derivative holding)SEC Form 423 June 2026Restricted Stock Units · traded 19 June 2026 · filed 23 June 2026
- exercised options over 14,248 shares of Axogen (a derivative holding)SEC Form 410 December 2025Employee Stock Option (right to purchase) · traded 9 December 2025 · filed 10 December 2025
- exercised options over 10,860 shares of Axogen (a derivative holding)SEC Form 410 December 2025Stock Option (right to purchase) · traded 9 December 2025 · filed 10 December 2025
- exercised options over 14,248 shares of AxogenSEC Form 410 December 2025Common Stock · traded 9 December 2025 · filed 10 December 2025
- exercised options over 10,860 shares of AxogenSEC Form 410 December 2025Common Stock · traded 9 December 2025 · filed 10 December 2025
- ▼ sold on the open market 14,248 shares of AxogenSEC Form 410 December 2025Common Stock · traded 9 December 2025 · filed 10 December 2025
- ▼ sold on the open market 10,860 shares of AxogenSEC Form 410 December 2025Common Stock · traded 9 December 2025 · filed 10 December 2025
- was granted 14,150 shares of Axogen (a derivative holding)SEC Form 420 June 2025Restricted Stock Units · traded 19 June 2025 · filed 20 June 2025
- exercised options over 7,586 shares of Axogen (a derivative holding)SEC Form 411 June 2025Stock Option (right to purchase) · traded 10 June 2025 · filed 11 June 2025
- exercised options over 4,000 shares of Axogen (a derivative holding)SEC Form 411 June 2025Employee Stock Option (right to purchase) · traded 10 June 2025 · filed 11 June 2025
- exercised options over 7,586 shares of AxogenSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- exercised options over 4,000 shares of AxogenSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- ▼ sold on the open market 26,931 shares of AxogenSEC Form 411 June 2025Common Stock · traded 10 June 2025 · filed 11 June 2025
- ▼ sold on the open market 2,525 shares of AxogenSEC Form 423 May 2025Common Stock · traded 19 May 2025 · filed 23 May 2025
- exercised options over 12,850 shares of Axogen (a derivative holding)SEC Form 423 May 2025Stock Option (right to purchase) · traded 22 May 2025 · filed 23 May 2025
- exercised options over 12,850 shares of AxogenSEC Form 423 May 2025Common Stock · traded 22 May 2025 · filed 23 May 2025
- ▼ sold on the open market 12,850 shares of AxogenSEC Form 423 May 2025Common Stock · traded 22 May 2025 · filed 23 May 2025
- ▼ sold on the open market 7,212 shares of AxogenSEC Form 423 May 2025Common Stock · traded 22 May 2025 · filed 23 May 2025
- ▲ bought on the open market 2,525 shares of AxogenSEC Form 46 January 2025Common Stock · traded 8 August 2024 · filed 6 January 2025
- exercised options over 11,904 shares of Axogen (a derivative holding)SEC Form 44 September 2024Restricted Stock Units · traded 1 September 2024 · filed 4 September 2024
- exercised options over 11,904 shares of AxogenSEC Form 44 September 2024Common Stock · traded 1 September 2024 · filed 4 September 2024
- was granted 18,248 shares of Axogen (a derivative holding)SEC Form 410 June 2024Employee Stock Option (right to purchase) · traded 6 June 2024 · filed 10 June 2024
- was granted 10,653 shares of AxogenSEC Form 410 June 2024Common Stock · traded 6 June 2024 · filed 10 June 2024
- was granted 20,436 shares of Axogen (a derivative holding)SEC Form 47 September 2023Stock Option (right to purchase) · traded 1 September 2023 · filed 7 September 2023
- was granted 11,904 shares of Axogen (a derivative holding)SEC Form 47 September 2023Restricted Stock Units · traded 1 September 2023 · filed 7 September 2023
- was granted 43,171 shares of Axogen (a derivative holding)SEC Form 415 December 2022Stock Option (right to purchase) · traded 13 December 2022 · filed 15 December 2022
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.